CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 124 enrolled
Drug / intervention
Risperidone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00080145
NCT00080145N/ACompleted
CompareCT.gov

Risperidone and Behavioral Therapy in Treatment of Children and Adolescents With Autistic Disorder

Yale University·interventional·Posted Mar 25, 2004·Updated Aug 16, 2013

In Brief

A clinical study evaluating Risperidone and Behavior Therapy for Child Development Disorders, Pervasive. Completed, enrolled 124 participants across 3 sites.

Detailed Summary

This 24-week study will compare the safety and effectiveness of medication treatment alone (risperidone or aripiprazole) to medication treatment in combination with a parent management training program.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChild Development Disorders, Pervasive
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 25, 2004
Enrollment StartFeb 1, 2004
Primary CompletionSep 1, 2007
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 22.3 years ago

Interventions

Risperidonedrug

Behavior Therapybehavioral